Macrogenics MGNX
NASDAQ MGNX
$2.34 +0.01 (+0.43%)
At close: Nov 9, 2026 · 4:00 PM EST

Macrogenics (MGNX) Liabilities from Discontinued Operations (2025)

Updated

Macrogenics' Liabilities from Discontinued Operations was $984,000 in Q4 2025.

Analysis

Macrogenics (MGNX) Liabilities from Discontinued Operations (2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,261.99 Bn 1,235.61 Bn 20.46 Bn
2 Johnson & Johnson 678.93 Bn 598.79 Bn 17.30 Bn
3 AbbVie 518.29 Bn 486.30 Bn 13.12 Bn
4 Merck 365.98 Bn 328.92 Bn 13.19 Bn
5 Novartis Ag 316.85 Bn 290.09 Bn -
6 Astrazeneca 293.40 Bn 267.29 Bn 13.26 Bn
7 Amgen 251.78 Bn 203.43 Bn 7.58 Bn
8 Gilead Sciences 210.61 Bn 185.71 Bn 6.73 Bn
9 Pfizer 166.87 Bn 114.23 Bn 12.56 Bn
10 Macrogenics 150.40 Mn -167.37 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 984,000.00
API Access

Macrogenics Liabilities from Discontinued Operations API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=liabilities-from-discontinued-operations&ticker=MGNX&period=max&api_key=YOUR_API_KEY